Can-Fite BioPharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.

CEO

Motti Farbstein

CEOMotti Farbstein

Employees

Employees5

Headquarters

Ramat Gan, HaMerkaz

HeadquartersRamat Gan, HaMerkaz

Founded

1994

Founded1994

Employees

Employees5

CANF Key Statistics

Market cap

5.87M

Market cap5.87M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

81.95K

Average volume81.95K

High today

$4.60

High today$4.60

Low today

$4.16

Low today$4.16

Open price

$4.23

Open price$4.23

Volume

77.76K

Volume77.76K

52 Week high

$46.60

52 Week high$46.60

52 Week low

$3.36

52 Week low$3.36

CANF News

TipRanks 4d

Can-Fite Completes Enrollment in Phase 2a Pancreatic Cancer Trial of Namodenoson

Claim 50% Off TipRanks Premium The latest announcement is out from Can-Fite BioPharma ( (CANF) ). On January 20, 2026, Can-Fite BioPharma announced it had com...

TipRanks 4d

Can-Fite completes patient enrollment in Phase 2a study of Namodenoson

Can-Fite BioPharma (CANF) announced that patient enrollment has been completed in its Phase 2a pancreatic cancer clinical trial of Namodenoson. The study is eva...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.